Skip to main content
Journal cover image

RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.

Publication ,  Journal Article
Li, Y; Xie, N; Chen, R; Lee, AR; Lovnicki, J; Morrison, EA; Fazli, L; Zhang, Q; Musselman, CA; Wang, Y; Huang, J; Gleave, ME; Collins, C; Dong, X
Published in: Eur Urol
August 2019

BACKGROUND: Prostate adenocarcinoma (AdPC) progression to treatment-induced neuroendocrine prostate cancer (t-NEPC) is associated with poor patient survival. While AdPC and t-NEPC share similar genomes, they possess distinct transcriptomes, suggesting that RNA splicing and epigenetic mechanisms may regulate t-NEPC development. OBJECTIVE: To characterize the role of alternative RNA splicing of the histone demethylase BHC80 during t-NEPC progression. DESIGN, SETTING, AND PARTICIPANTS: The expression of BHC80 splice variants (BHC80-1 and BHC80-2) were compared between AdPC and t-NEPC patient tumors. Regulatory mechanisms of RNA splicing of the BHC80 gene were studied, and the signal pathways mediated by BHC80 splice variants were investigated in t-NEPC cell and xenograft models. RESULTS: Global transcriptome analyses identified that the BHC80-2 variant is highly expressed in t-NEPC. Compared with the known histone demethylation activities of the BHC80 gene, we discovered a novel nonepigenetic action of BHC80-2, whereby BHC80-2 is localized in the cytoplasm to trigger the MyD88-p38-TTP pathway, which results in increased RNA stability of multiple tumor-promoting cytokines. While BHC80-2 does not induce neuroendocrine differentiation of cancer cells, it stimulates cell proliferation and tumor progression independent of androgen receptor signaling. Blockade of BHC80-2-regulated MyD88 signaling suppresses growth of several t-NEPC cell spheroid and xenograft models. CONCLUSIONS: Gain of function of BHC80-2 through alternative RNA splicing activates immune responses of cancer cells to promote t-NEPC development. PATIENT SUMMARY: The main obstacle to develop effective therapies for patients with t-NEPC is the lack of understanding on how t-NEPC is developed. Our study not only identifies a previously unknown BHC80-2-MyD88 signaling pathway that plays an important role during t-NEPC development, but also provides a proof of principle that targeting this signal pathway may offer an avenue to treat t-NEPC.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur Urol

DOI

EISSN

1873-7560

Publication Date

August 2019

Volume

76

Issue

2

Start / End Page

157 / 166

Location

Switzerland

Related Subject Headings

  • p38 Mitogen-Activated Protein Kinases
  • Urology & Nephrology
  • Tumor Cells, Cultured
  • Tristetraprolin
  • Spheroids, Cellular
  • Signal Transduction
  • RNA Splicing
  • Protein Isoforms
  • Prostatic Neoplasms
  • Neuroendocrine Tumors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, Y., Xie, N., Chen, R., Lee, A. R., Lovnicki, J., Morrison, E. A., … Dong, X. (2019). RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression. Eur Urol, 76(2), 157–166. https://doi.org/10.1016/j.eururo.2019.03.011
Li, Yinan, Ning Xie, Ruiqi Chen, Ahn R. Lee, Jessica Lovnicki, Emma A. Morrison, Ladan Fazli, et al. “RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.Eur Urol 76, no. 2 (August 2019): 157–66. https://doi.org/10.1016/j.eururo.2019.03.011.
Li Y, Xie N, Chen R, Lee AR, Lovnicki J, Morrison EA, et al. RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression. Eur Urol. 2019 Aug;76(2):157–66.
Li, Yinan, et al. “RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.Eur Urol, vol. 76, no. 2, Aug. 2019, pp. 157–66. Pubmed, doi:10.1016/j.eururo.2019.03.011.
Li Y, Xie N, Chen R, Lee AR, Lovnicki J, Morrison EA, Fazli L, Zhang Q, Musselman CA, Wang Y, Huang J, Gleave ME, Collins C, Dong X. RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression. Eur Urol. 2019 Aug;76(2):157–166.
Journal cover image

Published In

Eur Urol

DOI

EISSN

1873-7560

Publication Date

August 2019

Volume

76

Issue

2

Start / End Page

157 / 166

Location

Switzerland

Related Subject Headings

  • p38 Mitogen-Activated Protein Kinases
  • Urology & Nephrology
  • Tumor Cells, Cultured
  • Tristetraprolin
  • Spheroids, Cellular
  • Signal Transduction
  • RNA Splicing
  • Protein Isoforms
  • Prostatic Neoplasms
  • Neuroendocrine Tumors